vs
Astrana Health, Inc.（ASTH）与CARLISLE COMPANIES INC（CSL）财务数据对比。点击上方公司名可切换其他公司
CARLISLE COMPANIES INC的季度营收约是Astrana Health, Inc.的1.1倍（$1.1B vs $950.5M），CARLISLE COMPANIES INC净利率更高（12.1% vs 0.7%，领先11.4%），Astrana Health, Inc.同比增速更快（42.9% vs -4.0%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-73.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -14.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
卡莱尔公司是专业建筑产品供应商，聚焦于提升建筑能效与稳固性，面向商业建筑领域生产销售单层屋面产品、质保系统及配套配件，旗下设有卡莱尔建筑材料、卡莱尔防水技术两大业务板块，产品涵盖防潮材料、屋面防护层等多个品类。
ASTH vs CSL — 直观对比
营收规模更大
CSL
是对方的1.1倍
$950.5M
营收增速更快
ASTH
高出46.9%
-4.0%
净利率更高
CSL
高出11.4%
0.7%
自由现金流更多
ASTH
多$67.0M
$-73.0M
两年增速更快
ASTH
近两年复合增速
-14.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.1B |
| 净利润 | $6.6M | $127.7M |
| 毛利率 | — | 34.5% |
| 营业利润率 | 1.9% | 17.1% |
| 净利率 | 0.7% | 12.1% |
| 营收同比 | 42.9% | -4.0% |
| 净利润同比 | 184.4% | -10.9% |
| 每股收益（稀释后） | $0.12 | $3.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCSL
| Q1 26 | — | $1.1B | ||
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.4B | ||
| Q1 25 | $620.4M | $1.1B | ||
| Q4 24 | $665.2M | $1.1B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.5B |
净利润ASTHCSL
| Q1 26 | — | $127.7M | ||
| Q4 25 | $6.6M | $127.4M | ||
| Q3 25 | $373.0K | $214.2M | ||
| Q2 25 | $9.4M | $255.8M | ||
| Q1 25 | $6.7M | $143.3M | ||
| Q4 24 | $-7.8M | $162.8M | ||
| Q3 24 | $16.1M | $244.3M | ||
| Q2 24 | $19.2M | $712.4M |
毛利率ASTHCSL
| Q1 26 | — | 34.5% | ||
| Q4 25 | — | 33.8% | ||
| Q3 25 | — | 36.0% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 39.2% |
营业利润率ASTHCSL
| Q1 26 | — | 17.1% | ||
| Q4 25 | 1.9% | 16.8% | ||
| Q3 25 | 2.0% | 21.8% | ||
| Q2 25 | 3.1% | 23.1% | ||
| Q1 25 | 3.3% | 16.8% | ||
| Q4 24 | 0.1% | 19.9% | ||
| Q3 24 | 5.9% | 23.7% | ||
| Q2 24 | 6.2% | 26.0% |
净利率ASTHCSL
| Q1 26 | — | 12.1% | ||
| Q4 25 | 0.7% | 11.3% | ||
| Q3 25 | 0.0% | 15.9% | ||
| Q2 25 | 1.4% | 17.6% | ||
| Q1 25 | 1.1% | 13.1% | ||
| Q4 24 | -1.2% | 14.5% | ||
| Q3 24 | 3.4% | 18.3% | ||
| Q2 24 | 3.9% | 49.1% |
每股收益（稀释后）ASTHCSL
| Q1 26 | — | $3.10 | ||
| Q4 25 | $0.12 | $3.06 | ||
| Q3 25 | $0.01 | $4.98 | ||
| Q2 25 | $0.19 | $5.88 | ||
| Q1 25 | $0.14 | $3.20 | ||
| Q4 24 | $-0.14 | $3.76 | ||
| Q3 24 | $0.33 | $5.25 | ||
| Q2 24 | $0.40 | $14.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $771.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $1.7B |
| 总资产 | $2.2B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCSL
| Q1 26 | — | $771.3M | ||
| Q4 25 | $429.5M | $1.1B | ||
| Q3 25 | $463.4M | $1.1B | ||
| Q2 25 | $342.1M | $68.4M | ||
| Q1 25 | $260.9M | $220.2M | ||
| Q4 24 | $290.8M | $753.5M | ||
| Q3 24 | $350.3M | $1.5B | ||
| Q2 24 | $327.7M | $1.7B |
总债务ASTHCSL
| Q1 26 | — | — | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.3B |
股东权益ASTHCSL
| Q1 26 | — | $1.7B | ||
| Q4 25 | $779.3M | $1.8B | ||
| Q3 25 | $775.5M | $2.0B | ||
| Q2 25 | $765.5M | $2.1B | ||
| Q1 25 | $745.4M | $2.2B | ||
| Q4 24 | $712.7M | $2.5B | ||
| Q3 24 | $704.6M | $2.8B | ||
| Q2 24 | $678.9M | $3.0B |
总资产ASTHCSL
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | $6.3B | ||
| Q3 25 | $2.2B | $6.5B | ||
| Q2 25 | $1.4B | $5.5B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | $1.4B | $5.8B | ||
| Q3 24 | $1.3B | $6.5B | ||
| Q2 24 | $1.3B | $6.7B |
负债/权益比ASTHCSL
| Q1 26 | — | — | ||
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 0.77× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-73.0M |
| 自由现金流率自由现金流/营收 | -0.6% | -6.9% |
| 资本支出强度资本支出/营收 | 0.3% | 2.7% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $924.8M |
8季度趋势，按日历期对齐
经营现金流ASTHCSL
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $386.0M | ||
| Q3 25 | $10.0M | $426.9M | ||
| Q2 25 | $90.9M | $287.1M | ||
| Q1 25 | $16.6M | $1.8M | ||
| Q4 24 | $-10.9M | $370.6M | ||
| Q3 24 | $34.0M | $312.8M | ||
| Q2 24 | $23.2M | $183.4M |
自由现金流ASTHCSL
| Q1 26 | — | $-73.0M | ||
| Q4 25 | $-6.0M | $346.1M | ||
| Q3 25 | $7.4M | $393.4M | ||
| Q2 25 | $89.5M | $258.3M | ||
| Q1 25 | $13.6M | $-27.2M | ||
| Q4 24 | $-13.5M | $334.0M | ||
| Q3 24 | $31.7M | $293.5M | ||
| Q2 24 | $20.4M | $158.5M |
自由现金流率ASTHCSL
| Q1 26 | — | -6.9% | ||
| Q4 25 | -0.6% | 30.7% | ||
| Q3 25 | 0.8% | 29.2% | ||
| Q2 25 | 13.7% | 17.8% | ||
| Q1 25 | 2.2% | -2.5% | ||
| Q4 24 | -2.0% | 29.7% | ||
| Q3 24 | 6.6% | 22.0% | ||
| Q2 24 | 4.2% | 10.9% |
资本支出强度ASTHCSL
| Q1 26 | — | 2.7% | ||
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.2% | 2.0% | ||
| Q1 25 | 0.5% | 2.6% | ||
| Q4 24 | 0.4% | 3.3% | ||
| Q3 24 | 0.5% | 1.4% | ||
| Q2 24 | 0.6% | 1.7% |
现金转化率ASTHCSL
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 3.03× | ||
| Q3 25 | 26.69× | 1.99× | ||
| Q2 25 | 9.65× | 1.12× | ||
| Q1 25 | 2.48× | 0.01× | ||
| Q4 24 | — | 2.28× | ||
| Q3 24 | 2.11× | 1.28× | ||
| Q2 24 | 1.21× | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CSL
| CCM | $758.0M | 72% |
| CWT | $294.0M | 28% |
